Lv2
168 积分 2023-09-27 加入
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial
10天前
已完结
Association of Dietary Patterns with All-Cause and Cause-Specific Mortality in a High Cardiovascular Risk Population in China
2个月前
已完结
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
2个月前
已完结
Immunotherapy plus chemoradiotherapy in cervical cancer management
6个月前
已完结
Disagreement between self- and informant-reported memory complaints and progression of mild cognitive impairment to dementia
7个月前
已完结
Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial
7个月前
已完结
Planning green infrastructure placement based on projected precipitation data
7个月前
已完结
中国糖尿病防治指南（2024版）
11个月前
已完结
皖公网安备34019202002308
